Memorandum of Understanding and Agreement: Clinical Trials and Other Human-Use Protocols Involving Recombinant DNA and Biohazardous AgentsAugust 27th, 2022
FiledAugust 27th, 2022Deliberate transfer of rDNA, DNA, or RNA derived from recombinant DNA, into human research participants (human gene transfer) and/or application of biohazardous agents to human subjects requires completion/submission of this form to the Biosafety Officer.